Table 3.
Comparison of Various Parameters Among Patients With SARC-F Score ≥4 and SARC-F Score <4.
| SARC-F score ≥4 (n = 69) | SARC-F score <4 (n = 31) | P value | |
|---|---|---|---|
| Age (years) | 45.5 (1.1) | 42.1 (1.7) | 0.0001 |
| Gender (n) male:female | 60:9 | 26:5 | 0.7 |
| Etiology (n) alcohol:HCV:HBV:others | 56:7:6:0 | 24:1:2:4 | 0.6 |
| CTP class (n)- A:B:C | 0:26:43 | 0:16:15 | 0.19 |
| MVL—male:female [n (%)] | 42(70%): 8(88.9%) | 12(46.2): 0(0%) | 0.03; 0.002 |
| Body Mass Index—kg/m2 male:female | 20.7(4.4): 19.3 (1.7) | 22.6(4.0): 22.4(4.3) | 0.04; 0.0001 |
| MAC (inches) | 8.2 (1.5) | 9.3 (1.3) | <0.001 |
| Skin-fold thickness (mm) | 8 (5) | 13 (9) | <0.001 |
| MAMC (cms) | 17.8 (2.7) | 19.1 (1.7) | 0.01 |
| Hand-grip strength (Kg) | 9 (9) | 18 (11) | 0.0001 |
| Total bilirubin, mg/dL | 4.3 (3.8) | 5.3 (4.5) | 0.3 |
| Albumin, g/dL | 2.9 (0.5) | 2.8 (0.5) | 0.3 |
| INR | 1.8 (0.9) | 1.5 (0.5) | 0.1 |
| Creatinine, mg/L | 1.2 (0.6) | 1.2 (0.4) | 0.7 |
| Platelet count, 105/μl | 1.6 (0.8) | 1.1 (0.7) | 0.004 |
| ALT, U/L | 45 (30) | 48 (31) | 0.6 |
| AST, U/L | 49 (31) | 46 (29) | 0.6 |
CTP = Child–Turcotte–Pugh classification; MVL = muscle volume Loss; MAC = mid-arm circumference; MAMC = mid-arm muscle circumference; INR = international normalized ration; ALT = alanine transaminase; AST = aspartate aminotransferase; HBV = hepatitis B virus; HCV = hepatitis C virus; SARC-F = (S) strength, (A) assistance while walking, (R) rise from a chair, (C) climb stairs, and (F) falls.
Bold numbers indicates statistically significant values.